NPS Pharmaceuticals (NPSP) 45.97 $NPSP Shire to buy

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
NPS Pharmaceuticals (NPSP) 45.97 $NPSP

Shire to buy Baxalta for around $32 billion
M2 - Tue Jan 12, 6:03AM CST
"The target Baxalta and the orphan disease market are very compelling. The market is very attractive; worth $100+ Billion and has a CAGR of12 percent, almost twice of the general drugs market. Of the top 10 projected best-selling drugs world-wide in 2015, almost seven bear the orphan status. Additionally, the market has had favorable regulatory environment, having witnessed a record year for FDA/EU/Japan orphan designations in 2014."
NPSP: 45.97 (+0.01)

Progenics Pharmaceuticals Announces the Appointment of Patrick Fabbio as Chief Financial Officer
GlobeNewswire - Mon Nov 16, 6:30AM CST
Progenics Pharmaceuticals, Inc. (Nasdaq GNX) today announced appointment of Patrick Fabbio as Chief Financial Officer. Mr. Fabbio, the former Vice President, Global Corporate Finance at NPS Pharmaceuticals, Inc., has over 20 years of financial experience in the healthcare sector at both publicly-traded and privately-held companies.
PGNX: 5.96 (-0.18), NPSP: 45.97 (+0.01)

Global Biosimilars Market Report, 2015-2025 - The biosimilar market is projected to be worth USD 32 billion worldwide by 2025
PR Newswire Europe - Tue Nov 03, 11:11AM CST
Research and Markets (http://www.researchandmarkets.com/research/hcv3cc/global [http://www.researchandmarkets.com/research/hcv3cc/global]) has announced the addition of the "Global Biosimilars Market, 2015 - 2025" [http://www.researchandmarkets.com/research/hcv3cc/global] report to their offering.
BIIB: 313.59 (+7.56), UTHR: 122.91 (-0.30), CTIC: 0.39 (unch), CHRS: 30.81 (+0.83), JNJ: 119.32 (+0.24), NPSP: 45.97 (+0.01), IBIO: 0.59 (-0.02), EBS: 26.90 (+0.49), SLXP: 172.96 (+0.15), AMGN: 169.77 (-0.36), SPPI: 5.24 (-0.05), LLY: 76.85 (-0.38), GSK: 44.26 (+1.28), ANIK: 47.89 (-0.05), NVO: 45.80 (-0.54), BAX: 46.28 (+0.10), MRK: 62.98 (+0.08), NVS: 79.38 (+1.11)

Shire offers to buy Baxter drug spinoff for $30 billion
AP - Tue Aug 04, 3:29PM CDT
NEW YORK (AP) — The Irish drugmaker Shire is offering to buy Baxalta for about $30 billion in stock as it attempts to solidify its strengthening position in rare disease treatments.
BAX: 46.28 (+0.10), SHPG: 192.37 (+3.87), NPSP: 45.97 (+0.01), BXLT: 46.02 (-0.18)

Uptrend Call Working As NPS Pharmaceuticals Stock Rises 63.6% (NPSP)
Comtex SmarTrend(R) - Mon Apr 20, 11:12AM CDT
SmarTrend identified an Uptrend for NPS Pharmaceuticals (NASDAQ:NPSP) on October 20th, 2014 at $28.10. In approximately 6 months, NPS Pharmaceuticals has returned 63.62% as of today's recent price of $45.97.
NPSP: 45.97 (+0.01)

63.6% Return Seen to Date on SmarTrend NPS Pharmaceuticals Call (NPSP)
Comtex SmarTrend(R) - Mon Apr 13, 10:06AM CDT
SmarTrend identified an Uptrend for NPS Pharmaceuticals (NASDAQ:NPSP) on October 20th, 2014 at $28.10. In approximately 6 months, NPS Pharmaceuticals has returned 63.62% as of today's recent price of $45.97.
NPSP: 45.97 (+0.01)

NPS Pharmaceuticals Shares Up 63.6% Since SmarTrend's Buy Recommendation (NPSP)
Comtex SmarTrend(R) - Mon Apr 06, 9:18AM CDT
SmarTrend identified an Uptrend for NPS Pharmaceuticals (NASDAQ:NPSP) on October 20th, 2014 at $28.10. In approximately 6 months, NPS Pharmaceuticals has returned 63.62% as of today's recent price of $45.97.
NPSP: 45.97 (+0.01)

Shares of NPSP Up 63.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Mar 26, 4:47PM CDT
SmarTrend identified an Uptrend for NPS Pharmaceuticals (NASDAQ:NPSP) on October 20th, 2014 at $28.10. In approximately 5 months, NPS Pharmaceuticals has returned 63.62% as of today's recent price of $45.97.
NPSP: 45.97 (+0.01)

NPS Pharmaceuticals Has Returned 63.6% Since SmarTrend Recommendation (NPSP)
Comtex SmarTrend(R) - Thu Mar 19, 11:16AM CDT
SmarTrend identified an Uptrend for NPS Pharmaceuticals (NASDAQ:NPSP) on October 20th, 2014 at $28.10. In approximately 5 months, NPS Pharmaceuticals has returned 63.62% as of today's recent price of $45.97.
NPSP: 45.97 (+0.01)

Cynapsus Therapeutics Appoints Tamar Howson to Board of Directors
BusinessWire - Thu Mar 12, 3:10PM CDT
Cynapsus Therapeutics Inc. (TSX:CTH) (OTCQX:CYNAF), a specialty pharmaceutical company focused on the treatment of OFF episodes in Parkinson's disease, today announced that Tamar Howson has been appointed to the Company's Board of Directors. With the addition of Ms. Howson to the Board of Directors, the Company now has eight directors, with seven directors classified as independent.
OXGN: 0.70 (-0.03), NPSP: 45.97 (+0.01), BMY: 56.35 (-0.41), CTH.TO: 51.58 (-0.40)

Will NPS Pharmaceuticals (NPSP) Miss on Earnings in Q4? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 16, 12:00PM CST
NPS Pharmaceuticals (NPSP), which is expected to report fourth-quarter 2014 results on Feb 17, had posted a negative earnings surprise of 300% in the last quarter.
ACT: 298.98 (-2.94), SHPG: 192.37 (+3.87), NPSP: 45.97 (+0.01), ARIA: 10.12 (-0.07)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Apex Dental's Growth Shines in Inc. 5000 Ranking

Updated Category News Views 5

Another Year, Another Milestone for Apex Dental Let's talk about steady growth. Apex Dental Partners has made it onto the Inc. 5000 list for the eighth straight year, landing at No. 3,850. Quite a feat, considering this list only features America's fastest-growing private companies. Apex isn't just maintaining its position out of sheer luck. Revenue shot up by 67% over...

Continue Reading
Infrared Imaging Expands with AI, SWIR: Tech Trends

Updated Category News Views 5

Infrared Imaging: The Backbone of Future Tech Kinda wild how infrared imaging's become a hot topic in tech circles. With the market expected to jump from USD 9.2 billion in 2026 to a hefty USD 12.6 billion by 2031, averaging a 6.4% growth rate, there's plenty to chew on. Even if you ain't the analytical type, it ain't hard to spot where the money's flowing. Infrared's...

Continue Reading
EZ Elephant's Ladder-Free Gutter Fix Debuts at Expo

Updated Category News Views 4

A New Leaf in Gutter Maintenance From the ground up, EZ Elephant is redefining how we tackle gutter maintenance. Picture it: never having to teeter on that wobbly ladder again just to unclog your gutters. This American-made solution, showcased at the Western Roofing Expo from September 27–29, 2026, is a game changer. Check out Booth #834 to see this marvel of innovation...

Continue Reading
RunVermont Revamps City Marathon, Adds Half for 2027

Updated Category News Views 4

Straight outta Burlington, the M&T Bank Vermont City Marathon is giving its course a facelift and, get this, throwing a half marathon into the mix for 2027. It's about time they shook things up, considering how this race is supposed to be one of the most welcoming on the block. I mean, you're talking about a marathon that's practically been the crown jewel of Vermont's...

Continue Reading
First Lady Steals NYSE Show, Investors Eye Stakes

Updated Category News Views 4

Something's Buzzing at the Big Board Walk over to Wall Street on September 23rd, and guess what you get? A lot more than just stock tickers blinking away. First Lady Melania Trump’s stealing the show at the New York Stock Exchange to kick off the inaugural IMPERIA Summit. She’s there to sound the opening bell and lead the charge in a summit that's focused on the...

Continue Reading
Epiclay: Game Changer for Sculptors Debuts

Updated Category News Views 11

Epiclay™ Brings New Energy to Sculpting World Folks, if ever there was a time to break the mold, it’s now, and Ace of Clay’s got us covered with Epiclay™—a fresh take on polymer clay that’s turning heads in the sculpture circuit. Over four long years, Ace of Clay, a brand that's gathered a rather colorful following through captivating sculptures and detailed...

Continue Reading
Newmark's $482.5M Loan Fuels Steamboat Resort Expansion

Updated Category News Views 4

Newmark Banks on Steamboat's Future Diving headfirst into the deep end, Newmark (NASDAQ: NMRK) just roped in a colossal $482.5 million loan for a new gem in Steamboat Springs, Colorado. Inking a deal of this magnitude ain't your everyday rinse-and-repeat; it's a bold move that speaks volumes about where the big shots think value's heading. The Financial Fuel: GoldenTree...

Continue Reading
1.8M Moves in England: The Admin Maze Explained

Updated Category News Views 5

Navigating the Address Change Labyrinth Every time that welcome mat rolls out in a new spot, you're signing up for a mountain of paperwork. Sloth Move just painted a picture of the administrative mess awaiting those 1.8 million English households that decided 'new view, new digs' last year. Their analysis highlights why moving home means more than packing boxes—it's...

Continue Reading
Synopsys-TSMC Collaboration Drives AI System Evolution

Updated Category News Views 4

Synopsys and TSMC: The New Power Couple in AI Ah, the world of semiconductors—where the chips are small but the stakes are colossal. Once again, Synopsys and TSMC have thrown their hats into the ring, diving headfirst into yet another ambitious collaboration. Their latest mission? To fast-track the evolution of AI systems through a suite of innovations strapped to...

Continue Reading
Oracle Harnesses AI to Streamline Healthcare Payments

Updated Category News Views 8

Oracle Steps into Healthcare's Payment Arena You ever try solving a puzzle with half the pieces missing? Well, that's exactly what healthcare orgs have been doing with their revenue cycles. Oracle (NYSE:ORCL) thinks it’s got the missing pieces. They've announced some slick AI capabilities to grease the wheels of healthcare revenue management. But hey, I've seen grand...

Continue Reading

Top 5 Most Recently Viewed Articles

Discovering High-Grade Gold Opportunities Amid Market Shifts

Updated Category News Views 75

Unveiling Potential in the Gold Market In a rapidly evolving gold market, the recent surge in gold prices above $4,300 per ounce has sparked significant interest in high-grade gold deposits. This market scenario has created a unique advantage for firms showcasing premium quality deposits, as major new gold discoveries have become increasingly rare. Strategic Players in...

Continue Reading
Coppernico Metals Enhances Option Agreement to Boost Exploration

Updated Category News Views 113

Coppernico Metals Strengthens Exploration Efforts in Peru VANCOUVER, British Columbia — Coppernico Metals Inc. (TSX: COPR, OTCQB: CPPMF, FSE: 9I3) is excited to announce the amendments made to its option agreements to bolster its exploration programs at the Sombrero Project. Through its subsidiary, Sombrero Minerales SAC, the company has taken significant steps to...

Continue Reading
Apple Inc. Shares See Pre-Market Weakness: Insights and Analysis

Updated Category News Views 72

Apple's Share Performance in Pre-Market Trading Apple Inc. (NASDAQ: AAPL) recently experienced a notable decline in its stock during pre-market trading. Shares fell 2.03%, bringing them down to $221.32 from Thursday's close of $225.91. This unexpected drop can be attributed to the company’s cautious sales growth outlook for the upcoming quarter. Understanding the Recent...

Continue Reading
Mongolian Mining Corporation Joins OTCQX for Greater Reach

Updated Category News Views 85

Mongolian Mining Corporation Joins OTCQX for Enhanced Market Presence In an exciting development, Mongolian Mining Corporation, a prominent player in the high-quality washed hard coking coal sector, has made a significant advancement by listing on the OTCQX Best Market. This upgrade reflects the company's commitment to providing robust trading opportunities for U.S....

Continue Reading
ThreeD Capital Inc. Expands Stake in AI/ML Innovations Inc.

Updated Category News Views 281

ThreeD Capital Inc. Expands Stake in AI/ML Innovations Inc. ThreeD Capital Inc. (“ThreeD”) is a well-known Canadian venture capital firm that has recently strengthened its investment portfolio through a strategic acquisition. Through a private placement, ThreeD and its key associate Sheldon Inwentash have successfully acquired a substantial number of common shares of...

Continue Reading